Kelly Byrne

Tropical Clinical Trial Unit Manager

In 2005, Kelly began a BA in English Literature and Philosophy at the University of Central Lancashire before deciding to leave to pursue a career in clinical research administration and management.

Whilst working on several projects at the University of Manchester, Kelly obtained the skills to deliver complex drug trials in several disciplines including cardiovascular disease, musculoskeletal disorders and neuroscience and psychiatry. After working in clinical trials for 8 years, Kelly moved from the University of Manchester to the Liverpool School of Tropical Medicine in June 2017 to expand her expertise in tropical medicine, especially infectious diseases. She now works on a variety of trials, with both internal and external partners, to deliver specific services offered by the tropical Clinical Trials Unit (tCTU). These trials span over different infectious diseases including Malaria, TB, HIV and Influenza,

Kelly is a qualified PRINCE 2 Practitioner with strong trial management background.

Selected publications

  • Deakin, B., Suckling, J., Barnes, T.R.E., Byrne, K., Chaudhry, I.B., Dazzan, P., Drake, R.J., Giordano, A., Husain, N., Jones, P.B., Joyce, E., Knox, E., Krynicki, C., Lawrie, S.M., Lewis, S., Lisiecka-Ford, D.M., Nikkheslat, N., Pariante, C.M., Smallman, R., Watson, A., Williams, S.C.R., Upthegrove, R., Dunn, G.
    The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial
    The Lancet Psychiatry, Volume 5, Issue 11, November 2018